<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>MedWorm Tags: gates foundation</title>
        <description>MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'gates foundation'.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=%22gates+foundation%22&t=%22gates+foundation%22&r=Exact&o=d&f=tag]]></link>
        <lastBuildDate>Sat, 03 Sep 2011 02:11:54 +0100</lastBuildDate>
        <item>
            <title>&quot;The 'Third Rail' that No One Wishes to Analyze&quot; - Conflicts of Interest Affecting Health Care Foundations</title>
            <link>http://www.medworm.com/index.php?rid=4714693&amp;cid=t_153032_87_f&amp;fid=34765&amp;url=http%3A%2F%2Fhcrenewal.blogspot.com%2F2011%2F04%2Fthird-rail-that-no-one-wishes-to.html</link>
            <description>DiscussionWhile the data from this case-study were limited, they do suggest that major private foundations that support global health, and by extension, health care, services, and policy research may have institutional conflicts of interest, and their leaders may have personal conflicts of interest. It is possible that these conflicts have steered global health policy to favor vested interests, particularly&amp;nbsp;towards&amp;nbsp;approaches that&amp;nbsp;depend on drugs and devices, perhaps instead of more effective&amp;nbsp;ones&amp;nbsp;using less technology.Furthermore, it is possible that that these conflicts of interest have helped create the anechoic effect.&amp;nbsp; Conflicts of interest could&amp;nbsp;have&amp;nbsp;pushed the foundations&amp;nbsp;in directions that favored specific vested interests, and away from...</description>
            <author>Health Care Renewal</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4714693</comments>
            <pubDate>Thu, 14 Apr 2011 20:11:00 +0100</pubDate>
            <guid isPermaLink="false">4714693</guid>        </item>
        <item>
            <title>Foundations, Conflicts Of Interest And Drugmakers</title>
            <link>http://www.medworm.com/index.php?rid=4709422&amp;cid=t_153032_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2F2O5tLCPGn9c%2F</link>
            <description>Major philanthropic foundations, such as the Bill &amp;#038; Melinda Gates Foudation, regularly make the news with their donations and initiatives aimed at improving global health. But there is an aspect to their efforts that may be overlooked - such organizations can have links with drugmakers that could constitute a conflict of interest, according to an analysis published in PLoS Medicine. 
The researchers examined the five largest US private and/or family foundations that focus considerably on global health - besides the Gates Foundation, the list included the Ford Foundation; W K Kellogg Foundation; the Rockefeller Foundation and the Robert Wood Johnson Foundation, which is a philanthropic outgrowth of a Johnson &amp;#038; Johnson founder. They analyzed publicly available endowment disclosures...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4709422</comments>
            <pubDate>Wed, 13 Apr 2011 14:06:18 +0100</pubDate>
            <guid isPermaLink="false">4709422</guid>        </item>
        <item>
            <title>Pharmalot… Pharmalittle… Good Morning</title>
            <link>http://www.medworm.com/index.php?rid=4478155&amp;cid=t_153032_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FxQAoxKq3qM0%2F</link>
            <description>Rise and shine, everyone. Another day is on the way. Here on the chilly Pharmalot corporate campus, we are, once again, hustling the short people off to the school houses. Speaking of challenging routines, meetings and deadlines are also beckoning. We assume you can relate. By the way, we would like to remind you that we are co-sponsoring a patient adherence conference and hope you can join us. Meanwhile, the time has come for another cup of stimulation. Hope your day goes well and stay in touch&amp;#8230;
Oncology Investigators Needed To Maintain Patient Recruitment (Outsourcing Pharma)
EU Taken To Court Over Secrecy In India Trade Talks (Reuters)
Tachi Yamada Steps Down As Gates Foundation Health Leader (Xconomy)
FDA Approves Medical Devices Too Easily: Study (CBS News)
Watson Pharma Earning...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4478155</comments>
            <pubDate>Tue, 15 Feb 2011 13:16:41 +0100</pubDate>
            <guid isPermaLink="false">4478155</guid>        </item>
        <item>
            <title>After Publicity About Losses from Corruption, Now Will Any Health Charities Start Anti-Corruption Initiatives?</title>
            <link>http://www.medworm.com/index.php?rid=4450252&amp;cid=t_153032_87_f&amp;fid=34765&amp;url=http%3A%2F%2Fhcrenewal.blogspot.com%2F2011%2F02%2Fafter-publicity-about-losses-from.html</link>
            <description>Over the last few weeks a series of stories appeared about how corruption siphons off money from worthy global health initiatives.&amp;nbsp; Corruption Depletes Global Fund to Fight AIDS, Tuberculosis and MalariaThe story that first got attention was from AP:A $21.7 billion development fund backed by celebrities and hailed as an alternative to the bureaucracy of the United Nations sees as much as two-thirds of some grants eaten up by corruption, The Associated Press has learned.Much of the money is accounted for with forged documents or improper bookkeeping, indicating it was pocketed, investigators for the Global Fund to Fight AIDS, Tuberculosis and Malaria say. Donated prescription drugs wind up being sold on the black market.The fund's newly reinforced inspector general's office, which unco...</description>
            <author>Health Care Renewal</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4450252</comments>
            <pubDate>Tue, 08 Feb 2011 21:05:00 +0100</pubDate>
            <guid isPermaLink="false">4450252</guid>        </item>
        <item>
            <title>Bill Gates At mHealth: How Mobile Health Can Improve Healthcare</title>
            <link>http://www.medworm.com/index.php?rid=4179323&amp;cid=t_153032_87_f&amp;fid=39187&amp;url=http%3A%2F%2Fgetbetterhealth.com%2Fbill-gates-at-mhealth-how-mobile-health-can-improve-healthcare%2F2010.11.18</link>
            <description>We reported last week from the mHealth Summit in Washington, DC -- a conference covering the integration of mobile technologies with medical research, information, diagnosis, treatment, and care.]
One of the highlights of last week’s mHealth Summit was the keynote interview of Bill Gates. While inseparable from his history as founder and leader of Microsoft from 1975 to 2008, his current passion is global health.
Through the Bill and Melinda Gates Foundation, which has now given 3.8 billion (with a “b&amp;#8221;) of targeted philanthropy into global health since 1994, he and his wife Melinda are helping bring about profound change to the lives of millions around the world. In a meeting dedicated to exploring the power of mobile devices to shape health in developed and developing countr...</description>
            <author>Better Health</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4179323</comments>
            <pubDate>Thu, 18 Nov 2010 13:00:56 +0100</pubDate>
            <guid isPermaLink="false">4179323</guid>        </item>
        <item>
            <title>New DNA PCR Test For Tuberculosis Shows Great Promise For Speedy Diagnosis and Treatment</title>
            <link>http://www.medworm.com/index.php?rid=3924816&amp;cid=t_153032_83_f&amp;fid=34856&amp;url=http%3A%2F%2Finsidesurgery.com%2F2010%2F09%2Fdna-pcr-test-tuberculosis-shows-great-promise-speedy-diagnosis-treatment%2F</link>
            <description>A new testing method to determine if a patient is infected with tuberculosis has been developed by a consortium of research institutions with funding coming from the Bill and Melinda Gates Foundation. Drs. Peter Small and Mario Raviglione comment. (Source: Inside Surgery)</description>
            <author>Inside Surgery</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3924816</comments>
            <pubDate>Thu, 02 Sep 2010 02:32:29 +0100</pubDate>
            <guid isPermaLink="false">3924816</guid>        </item>
        <item>
            <title>Male Birth Control: Is Ultrasound The Key?</title>
            <link>http://www.medworm.com/index.php?rid=3592213&amp;cid=t_153032_87_f&amp;fid=39187&amp;url=http%3A%2F%2Fgetbetterhealth.com%2Fmale-birth-control-is-ultrasound-the-key%2F2010.05.23</link>
            <description>Finally men everywhere might have a birth control option that won&amp;#8217;t rob them of the joys of living.
Scientists at the University of North Carolina at Chapel Hill may have discovered a cheap, convenient and noninvasive method of male birth control &amp;#8212; ultrasound. The scientists believe that a single treatment can provide up to six months of infertility that is reversible.
The team has received a $100,000 Grand Challenges Explorations grant from the Bill and Melinda Gates Foundation for their work. If the project pans out, this could have an incredible impact on global health. (more&amp;#8230;)

			
			*This blog post was originally published at Medgadget* (Source: Better Health)</description>
            <author>Better Health</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3592213</comments>
            <pubDate>Sun, 23 May 2010 12:00:51 +0100</pubDate>
            <guid isPermaLink="false">3592213</guid>        </item>
        <item>
            <title>FDA To Devise New Guidelines For Drug Cocktails</title>
            <link>http://www.medworm.com/index.php?rid=3378732&amp;cid=t_153032_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2Fj_XwUiio9VA%2F</link>
            <description>The move is designed to jumpstart testing and approval of new regimens for so-called drug cocktails to combat tuberculosis, AIDS and cancer. The guidelines would apply only to drugs for life-threatening illnesses for which options don&amp;#8217;t already exist, and that drug cocktails are believed necessary.
Among those involved: the Critical Path to TB Regimens, which includes Pfizer, Sanofi-Aventis, AstraZeneca, GlaxoSmithKline and a unit of Johnson &amp; Johnson; Global Alliance for TB Drug Development, the Critical Path Institute and Treatment Action Group, as well as the Bill &amp;#038; Melinda Gates Foundation. The companies have agreed to share data and test combo treatments.
&amp;#8220;This represents a bigger issue - the strengthening of regulatory science&amp;#8221; to encompass scientific advances,...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3378732</comments>
            <pubDate>Thu, 18 Mar 2010 11:10:42 +0100</pubDate>
            <guid isPermaLink="false">3378732</guid>        </item>
        <item>
            <title>Private Sector Contribution to Developing Countries’ Health Unheralded</title>
            <link>http://www.medworm.com/index.php?rid=3096855&amp;cid=t_153032_87_f&amp;fid=38368&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FDisruptiveWomenInHealthCare%2F%7E3%2Fbcq6qZOsmlU%2F</link>
            <description>The following guest post by Susan Crowley, President of Multilateral Consulting, LLC, is part of Disruptive Women&amp;#8217;s &amp;#8220;The Value of Health: Creating Economic Security in the Developing World&amp;#8221; series.
By any measure, giving programs directed at developing countries by research-based pharmaceutical companies are the most generous of any industry. The Geneva-based International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), whose methodology and data presented in its most recent “Partnerships Report” were validated by the London School of Economics, reported $6.7 billion in giving.
The 2009 “Index on Global Philanthropy,” published by the Hudson Institute, provides a measure of global private giving and, once again, demonstrates that private flows...</description>
            <author>Disruptive Women in Health Care</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3096855</comments>
            <pubDate>Wed, 16 Dec 2009 14:23:47 +0100</pubDate>
            <guid isPermaLink="false">3096855</guid>        </item>
        <item>
            <title>Gates Foundation to fund global informatics training</title>
            <link>http://www.medworm.com/index.php?rid=2021293&amp;cid=t_153032_113_f&amp;fid=34625&amp;url=http%3A%2F%2Fclinicalit.blogspot.com%2F2008%2F12%2Fgates-foundation-to-fund-global.html</link>
            <description>The American Medical Informatics Association will announce Monday that it has received a $1.2 million grant from the Bill and Melinda Gates Foundation to promote health informatics and biomedical education and training worldwide, particularly in developing countries.This will be the first project of a new program called 20/20, in which the International Medical Informatics Association and its regional affiliates, including AMIA, will attempt to train 20,000 informatics professionals globally by 2020. This is an outgrowth of the AMIA 10x10 program to train 10,000 people in informatics in the U.S. by 2010. IMIA and its partners will discuss details of 20/20 this week at the Wellcome Trust in London.AMIA will use the Gates Foundation money to develop &quot;scaleable&quot; approaches to e-health educati...</description>
            <author>Neil Versel's Healthcare IT Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2021293</comments>
            <pubDate>Mon, 08 Dec 2008 05:40:00 +0100</pubDate>
            <guid isPermaLink="false">2021293</guid>        </item>
        <item>
            <title>Pharmalot… Pharmalittle… G’Morning, Luv</title>
            <link>http://www.medworm.com/index.php?rid=1955507&amp;cid=t_153032_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F449466213%2F</link>
            <description>Nice to you see again, too. A nippy start here on the Pharmalot corporate campus, where the heat seems to be missing in action. Nonetheless, we must persevere as we transport the short people to their schoolhouses. Meanwhile, we have found a few items that may generate some heat of their own&amp;#8230;
Indiana Woman Sues Pfizer Over PCB Contamination (The Tribune-Star)
Celgene Stem Cell Therapy Gets FDA OK For Human Trials (Reuters)
Merck/J&amp;#038;J Recall Infant Gas Drops (Bloomberg News)
New Zealand Court Tells AstraZeneca To Comply With Inquiry (news3)
Glaxo, XenoPort Yank Restless Leg Drug Application (Associated Press)
Large Malaria Trial To Begin In Africa (Associated Press) (Source: Pharmalot)</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1955507</comments>
            <pubDate>Tue, 11 Nov 2008 12:05:02 +0100</pubDate>
            <guid isPermaLink="false">1955507</guid>        </item>
        <item>
            <title>BIO 2008: Doing Well by Doing Good: Can Venture Capital Improve Drug Accessibility?</title>
            <link>http://www.medworm.com/index.php?rid=1531703&amp;cid=t_153032_150_f&amp;fid=35779&amp;url=http%3A%2F%2Fwww.pharmamanufacturing.com%2Fonpharma%2F%3Fp%3D2111</link>
            <description>On Tuesday afternoon, a panel discussed ways in which corporations might be able to stimulate the development of more therapies for serious diseases&amp;#8212;-the world’s top killers such as malaria. The topic is one that I’m very interested, but, unfortunately, I arrived late and missed much of the discussion.
Genzyme has been doing some pioneering work with [...] (Source: On Pharma)</description>
            <author>On Pharma</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1531703</comments>
            <pubDate>Fri, 20 Jun 2008 14:49:31 +0100</pubDate>
            <guid isPermaLink="false">1531703</guid>        </item>
        <item>
            <title>Thoughts on a Science Exchange</title>
            <link>http://www.medworm.com/index.php?rid=1379434&amp;cid=t_153032_132_f&amp;fid=35011&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2Fmndoci%2F%7E3%2F272192025%2F</link>
            <description>Cameron has written a wonderful post about a Science Exchange, distilling a varied set of thoughts, including one by Shirley. It&amp;#8217;s clear there are problems and that we need a new system.

 I also feel that our future doesn&amp;#8217;t lie just with government funding, but increasingly with institutions like the Gates Foundation, or Google.org. Perhaps such an exchange can be funded by a combination of micro-funding and &amp;#8220;investors&amp;#8221;, who, in essence are enabling the future. If one can layer something like iBridge Network on top of that, that would be even better
That said, I would not mind seeing the scientific equivalent (or equivalents) of Stackoverflow for starters. We need that too. 
Technorati Tags: Microfunding, Science Exchange, Collaboration

ShareThis (Source: business...</description>
            <author>business|bytes|genes|molecules</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1379434</comments>
            <pubDate>Thu, 17 Apr 2008 14:11:07 +0100</pubDate>
            <guid isPermaLink="false">1379434</guid>        </item>
        <item>
            <title>Are Cure and “Eradication” Not the Only Goal?</title>
            <link>http://www.medworm.com/index.php?rid=1280786&amp;cid=t_153032_133_f&amp;fid=35096&amp;url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FAutismVox%2F%7E3%2F246252110%2F</link>
            <description>There&amp;#8217;s talk about curing and preventing autism, but is this really possible? Is it where all the funds raised in the name of &amp;#8220;autism research&amp;#8221; should be directed? What about focusing on helping those who already have autism&amp;#8212;on autistic persons now and today?
Compare a recent discussion about eradicating malaria. Maybe eradiction isn&amp;#8217;t the right aim to direct research efforts towards, experts about the disease note in an article in the March 4th New York Times. Are scientists feeling they have to talk about &amp;#8220;eradicating&amp;#8221; malaria&amp;#8212;which Bill and Melinda Gates called for last year&amp;#8212;-although funds might be rather spent in keeping numbers down and managing the disease?
Dr. Arata Kochi, the W.H.O. malaria chief, went further than other skepti...</description>
            <author>Autism Vox</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1280786</comments>
            <pubDate>Wed, 05 Mar 2008 17:44:07 +0100</pubDate>
            <guid isPermaLink="false">1280786</guid>        </item>
        <item>
            <title>Science:  money = influence</title>
            <link>http://www.medworm.com/index.php?rid=1239283&amp;cid=t_153032_87_f&amp;fid=35052&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FWomensBioethicsBlog%2F%7E3%2F237102192%2Fscience-money-influence.html</link>
            <description>According to the NYT, a memo critical of the role of the Gates Foundation's increasing role in global health research and policy was recently released to the media. The World Health Organization's...

[[ This is a content summary only. Visit my website for full links, other content, and more! ]] (Source: Women's Bioethics Blog)</description>
            <author>Women's Bioethics Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1239283</comments>
            <pubDate>Mon, 18 Feb 2008 18:13:49 +0100</pubDate>
            <guid isPermaLink="false">1239283</guid>        </item>
        <item>
            <title>10 Highlights from the 2007 Aspen Health Forum</title>
            <link>http://www.medworm.com/index.php?rid=966550&amp;cid=t_153032_122_f&amp;fid=36582&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FSharpBrains%2F%7E3%2F167009901%2F</link>
            <description>The Aspen Health Forum gathered an impressive group of around 250 people to discuss the most pressing issues in Health and Medical Science (check out the Program and the Speakers bios), on October 3-6th. It was the first conference, by the way, where I have heard a speaker say: &amp;quot;I resuscitated a woman yesterday&amp;quot;.
Key highlights and trends:
1- Global health problems require the attention of the scientific community. Richard Klausner encouraged the scientific community to focus on Global Problems: maternal mortality rates, HIV/ AIDS, nutrition, cancer, clean water.  Bill Frist, former Senate Majority Leader, added to that list the increasing epidemic risks of global zootic diseases (transmitted between humans and animals), supported by 2 interesting data points: at any ...</description>
            <author>SharpBrains</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=966550</comments>
            <pubDate>Mon, 08 Oct 2007 16:09:01 +0100</pubDate>
            <guid isPermaLink="false">966550</guid>        </item>
        <item>
            <title>On The Couch… Weekend Reading</title>
            <link>http://www.medworm.com/index.php?rid=915414&amp;cid=t_153032_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F163271037%2F</link>
            <description>Finished the chores? Curling up with a cup of coffee? Trying to relax? Then the time has come to catch up on events. Here are a few items to enjoy before you head off to pick some apples or talk a walk in the park&amp;#8230;
Drugmakers often complain their good deeds go unnoticed, or worse. So Time magazine has run a piece about Merck&amp;#8217;s efforts to provide HIV meds in Botswana. The drugmaker wins praise from its partner, the government and Gates Foundation, although the mag doesn&amp;#8217;t bother to ask one of the NGOs, or non-governmental organizations, for a quick comment.
Novartis ceo Dan Vasella, who has felt the sting of rejected drugs more than once lately, complains that the FDA has become politicized. &amp;#8220;The FDA has become subject to politics. If they are assailed like they are ...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=915414</comments>
            <pubDate>Sun, 30 Sep 2007 17:02:19 +0100</pubDate>
            <guid isPermaLink="false">915414</guid>        </item>
    </channel>
</rss>

